[{"address1": "4868 Rue Levy", "address2": "Suite 220", "city": "Montreal", "state": "QC", "zip": "H4R 2P1", "country": "Canada", "phone": "514 332 4888", "website": "https://www.engene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Gu\u00e9rin (BCG). enGene Holdings Inc. is based in Montreal, Canada.", "fullTimeEmployees": 56, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ronald H. W. Cooper", "age": 61, "title": "President, CEO & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 963267, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony T. Cheung Ph.D.", "age": 52, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 341754, "exercisedValue": 0, "unexercisedValue": 13448566}, {"maxAge": 1, "name": "Mr. John C. Brown D.Sc., FRSC, Ph.D.", "title": "Co-Founder and Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Ryan Daws", "age": 50, "title": "CFO & Head of Business Development", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alexander  Nichols Ph.D.", "age": 38, "title": "Chief Strategy & Operations Officer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 504442, "exercisedValue": 0, "unexercisedValue": 3900970}, {"maxAge": 1, "name": "Ms. Joan  Connolly", "age": 54, "title": "Chief Technology Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee G. Giguere", "age": 44, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tara  Place M.B.A.", "title": "Senior VP of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew  Boyd", "title": "Senior VP of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jill  Buck", "age": 50, "title": "Senior VP of Clinical Development Operations", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.15, "open": 3.19, "dayLow": 2.94, "dayHigh": 3.19, "regularMarketPreviousClose": 3.15, "regularMarketOpen": 3.19, "regularMarketDayLow": 2.94, "regularMarketDayHigh": 3.19, "payoutRatio": 0.0, "beta": -0.391, "forwardPE": -1.7869822, "volume": 178718, "regularMarketVolume": 178718, "averageVolume": 74575, "averageVolume10days": 115990, "averageDailyVolume10Day": 115990, "bid": 0.0, "ask": 3.03, "bidSize": 0, "askSize": 1, "marketCap": 154337696, "fiftyTwoWeekLow": 2.65, "fiftyTwoWeekHigh": 11.0, "fiftyDayAverage": 3.6978, "twoHundredDayAverage": 6.052, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -37694292, "profitMargins": 0.0, "floatShares": 24469681, "sharesOutstanding": 51105200, "sharesShort": 39578, "sharesShortPriorMonth": 69717, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0008, "heldPercentInsiders": 0.13572, "heldPercentInstitutions": 0.77663004, "shortRatio": 0.44, "shortPercentOfFloat": 0.001, "impliedSharesOutstanding": 53305100, "bookValue": 4.451, "priceToBook": 0.67849916, "lastFiscalYearEnd": 1730332800, "nextFiscalYearEnd": 1761868800, "mostRecentQuarter": 1745971200, "netIncomeToCommon": -79878000, "trailingEps": -1.63, "forwardEps": -1.69, "enterpriseToEbitda": 0.429, "52WeekChange": -0.6271605, "SandP52WeekChange": 0.10163462, "quoteType": "EQUITY", "currentPrice": 3.02, "targetHighPrice": 30.0, "targetLowPrice": 7.0, "targetMeanPrice": 21.81818, "targetMedianPrice": 23.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 11, "totalCash": 217392000, "totalCashPerShare": 4.254, "ebitda": -87810000, "totalDebt": 25360000, "quickRatio": 12.106, "currentRatio": 12.665, "debtToEquity": 11.158, "returnOnAssets": -0.20352, "returnOnEquity": -0.33972, "freeCashflow": -47369000, "operatingCashflow": -75392000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ENGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "enGene Holdings Inc.", "corporateActions": [], "regularMarketTime": 1750708802, "exchange": "NCM", "messageBoardId": "finmb_9516520", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": -0.13, "regularMarketDayRange": "2.94 - 3.19", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 74575, "fiftyTwoWeekLowChange": 0.3699999, "fiftyTwoWeekLowChangePercent": 0.1396226, "fiftyTwoWeekRange": "2.65 - 11.0", "fiftyTwoWeekHighChange": -7.98, "fiftyTwoWeekHighChangePercent": -0.72545457, "fiftyTwoWeekChangePercent": -62.71605, "earningsTimestampStart": 1757559600, "earningsTimestampEnd": 1758855600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.63, "epsForward": -1.69, "epsCurrentYear": -1.98665, "priceEpsCurrentYear": -1.520147, "fiftyDayAverageChange": -0.67779994, "fiftyDayAverageChangePercent": -0.18329817, "twoHundredDayAverageChange": -3.032, "twoHundredDayAverageChangePercent": -0.5009914, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-11-01", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1643725800000, "regularMarketChangePercent": -4.12699, "regularMarketPrice": 3.02, "marketState": "PRE", "shortName": "enGene Holdings Inc.", "displayName": "enGene", "trailingPegRatio": null, "__fetch_time": "2025-06-24"}]